ELIZABETH MARTIN: Open Payments
NPI 1487359741 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,518 in 26 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $542 · 2025 $1,518
Long term medical supply or device loan: $698Food & beverage: $646Education: $174
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $698 |
| Novo Nordisk Inc | 4 | $237 |
| Incyte Corporation | 3 | $230 |
| ABBVIE INC. | 2 | $124 |
| Geron Corporation | 1 | $31 |
| Tempus AI, Inc | 1 | $30 |
| TerSera Therapeutics LLC | 1 | $27 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
| Aveo Pharmaceuticals, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: KISQALI, Jakafi, Ozempic, Wegovy, IMBRUVICA, RYTELO, XT CDX, Quzyttir.
Industry payments across VA — which companies pay providers there.
